Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc. - Amendment

4 Nov 2015 15:30

RNS Number : 5963E
JPMorgan Asset Management
04 November 2015
 

 

 

AMENDMENT

FORM 8.3

 

IRISH TAKEOVER PANEL

 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

JPMorgan Asset Management

Company dealt in

Pfizer Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

02 November 2015

 

 

2. INTERESTS AND SHORT POSITIONS 

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

 

Long

Short

 

 

Number

(%)

Number

(%)

(1) Relevant securities

 

85,813,549 *

1.39

(2) Derivatives (other than options)

 

208,388

0.00

(3) Options and agreements to purchase/sell

 

Total

 

86,021,937*

1.39

*In addition to the dealings in section 3, there is an increase in the holding of 1,992 shares due to a transfer.

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

 

Long

Short

 

 

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

 

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

 

Number of relevant securities

Price per unit

(USD)

Purchase

Purchase

 

Sale

Sale

Sale

3,977

120

 

 9,120

109

 240

35.0600 USD

35.0978 USD

 

35.0600 USD

35.0710 USD

35.1200 USD

 

 

 

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)

NO

 

Date of disclosure

04 November 2015

Contact name

Evangelos Galiatsatos

Telephone number

0207 742 6148

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

 

 

The Notes on Form 8.3 can be viewed on the Panel's website at www.irishtakeoverpanel.ie. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEFSSFILFISEDF
Date   Source Headline
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 20149:21 amRNSRule 2.10 Announcement
22nd May 20149:14 amBUSForm 8.3 - Pfizer Inc
22nd May 20147:00 amPRNForm 8.3 - Pfizer Inc.
21st May 20145:35 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
21st May 20145:28 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:23 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:22 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:13 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:09 pmRNSForm 8 (DD) - Pfizer Inc
21st May 20145:08 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20143:44 pmRNSForm 8.3 - Pfizer Inc
21st May 20143:32 pmRNSForm 8.3 - Astrazeneca PLC
21st May 20143:31 pmRNSForm 8.3 - [Pfizer Inc]
21st May 20143:17 pmRNSForm 8.3 -Pfizer Inc
21st May 20143:15 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:57 pmRNSForm 8.3 - [PFIZER INC]
21st May 20142:56 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:46 pmRNSForm 8 (DD) - Pfizer Inc.
21st May 20142:46 pmBUSForm 8.3 - Pfizer Inc.
21st May 20142:42 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:25 pmBUSForm 8.3 - Pfizer Inc
21st May 20141:23 pmRNSForm 8.3 - Pfizer Inc
21st May 20141:22 pmRNSForm 8.3 - AstraZeneca Plc
21st May 201412:35 pmBUSForm 8.3 - Pfizer Inc
21st May 201412:07 pmRNSForm 8.5 (EPT/NON-RI) Amendment
21st May 201411:55 amRNSForm 8.3 - Pfizer Inc.
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:40 amRNSForm 8.3 - Pfizer Inc
21st May 201411:37 amRNSForm 8 (DD) - [Pfizer Inc]
21st May 201411:33 amRNSForm 8.5 (EPT/RI)
21st May 201411:29 amRNSRule 2.10 Announcement
21st May 201411:28 amRNSForm 8.5 (EPT/NON-RI)
21st May 201411:22 amRNSForm 8.5 (EPT/RI)
21st May 201411:09 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:08 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:07 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:04 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201410:32 amRNSRule 2.10 Announcement
21st May 201410:27 amRNSForm 8.3 - Pfizer Inc
21st May 20147:00 amPRNForm 8.3 - Pfizer Inc.
20th May 20146:17 pmRNSCLARIFICATION REGARDING PFIZER STATEMENT
20th May 20145:13 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
20th May 20144:54 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
20th May 20144:31 pmBUSForm 8.3 - Pfizer Inc
20th May 20143:47 pmRNSForm 8.3 - [PFIZER INC]
20th May 20143:36 pmRNSForm 8.3 - Pfizer Inc
20th May 20143:23 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.